NCT06584123View on ClinicalTrials.gov

Molecular Pituitary Imaging Using 18F-FET PET

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 3, 2024

Primary Completion Date

September 2, 2026

Study Completion Date

December 31, 2026

Conditions
Pituitary Adenoma
Interventions
DIAGNOSTIC_TEST

18F-Fluoro-ethyl-tyrosine (FET) PET

18F-Fluoro-ethyl-tyrosine PET study of the pituitary

All Listed Sponsors
collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

lead

University of Cambridge

OTHER

NCT06584123 - Molecular Pituitary Imaging Using 18F-FET PET | Biotech Hunter | Biotech Hunter